Antibody Engineering and Therapeutic Applications
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 52
Special Issue Editor
Interests: therapeutic antibody; cancer immunotherapy; antibody engineering; structure and mechanism of antibody drugs; protein structure
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in antibody-mediated therapies have markedly enhanced their clinical efficacy. Cancer immunotherapy has drastically altered the treatment of multiple types of tumors, leading to the approval of monoclonal antibodies for checkpoint inhibition, CAR-T cell therapies, T-cell engagers, and bispecific antibod-ies. Antibody-drug conjugates (ADCs) represent one of the most swiftly blooming therapeutic modalities in oncology, with 12 ADCs approved by the FDA and over 300 currently undergoing clinical investigations.
The design and clinical application of monoclonal antibody (mAb) therapeutics ne-cessitate thoroughly comprehending the intricate relationship between their struc-ture and function. Recent breakthroughs in artificial intelligence (AI) methodologies have made significant progress in the generation of protein sequences and struc-tures, enabling the de novo design of antibodies capable of binding to specific sur-faces of target proteins.
This Special Issue aims to address recent advancements and innovative concepts in the design and application of cutting-edge antibody-mediated therapies, including but not limited to mAb therapeutics, biosimilars, antibody-drug conjugates (ADCs), bispecific and multispecific antibodies, T-cell engagers (TCEs), CAR-T or CAR-NK therapies, nanobodies, immunocytokines, antibody-targeted nanoparticles, antibody structure and mechanism of action, antibody engineering, and AI-driven antibody design. Original papers and review articles are welcome.
Prof. Dr. Yong-Seok Heo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- monoclonal antibody (mAb) therapies
- antibody engineering
- antibody-drug conjugate (ADC)
- chimeric antigen receptor T cell (CAR-T)
- bispecific antibody
- T-cell engager (TCE)
- cancer immunotherapy
- immunocytokine
- AI-driven antibody design
- antibody structure and mechanism of action
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.